E-LIB Suche - Ergebnisse für: Walter, R B

1

P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WIT..:

Uy, G. L. ; Pullarkat, V. A. ; Baratam, P....
HemaSphere. 6 (2022) - p. 414-415 , 2022

Link: https://doi.org/10.1097/..

2

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMG..:

Pemmaraju, N. ; Martinelli, G. ; Todisco, E....
HemaSphere. 6 (2022) - p. 1708-1709 , 2022

Link: https://doi.org/10.1097/..

3

P555: A PHASE 1B/2 STUDY OF THE CD123-TARGETING ANTIBODY-DR..:

Daver, N. G. ; Montesinos, P. ; Aribi, A....
HemaSphere. 6 (2022) - p. 454-455 , 2022

Link: https://doi.org/10.1097/..

4

Mitoxantrone, etoposide and cytarabine following epigenetic..:

Halpern, A B ; Othus, M ; Huebner, E M...
Leukemia. 31 (2017) 12 - p. 2560-2567 , 2017

Link: https://doi.org/10.1038/..

5

Is there a need for morphologic exam to detect relapse in A..:

Zhou, Y ; Wood, B L ; Walter, R B...
Leukemia. 31 (2017) 11 - p. 2536-2537 , 2017

Link: https://doi.org/10.1038/..

6

Characteristics and outcome of patients with therapy-relate..:

Kayser, S ; Krzykalla, J ; Elliott, M A...
Leukemia. 31 (2017) 11 - p. 2347-2354 , 2017

Link: https://doi.org/10.1038/..

7

Measurable residual disease testing in acute myeloid leukae..:

Hourigan, C S ; Gale, R P ; Gormley, N J..
Leukemia. 31 (2017) 7 - p. 1482-1490 , 2017

Link: https://doi.org/10.1038/..

8

Gemtuzumab ozogamicin in acute myeloid leukemia:

Godwin, C D ; Gale, R P ; Walter, R B
Leukemia. 31 (2017) 9 - p. 1855-1868 , 2017

Link: https://doi.org/10.1038/..

9

Patients treated for acute VTE during periods of treatment-..:

Samuelson Bannow, B. T. ; Walter, R. B. ; Gernsheimer, T. B..
Journal of Thrombosis and Thrombolysis. 44 (2017) 4 - p. 442-447 , 2017

Link: https://doi.org/10.1007/..

10

Pre- and post-transplant quantification of measurable ('min..:

Zhou, Y ; Othus, M ; Araki, D...
Leukemia. 30 (2016) 7 - p. 1456-1464 , 2016

Link: https://doi.org/10.1038/..

11

Effect of measurable ('minimal') residual disease (MRD) inf..:

Othus, M ; Wood, B L ; Stirewalt, D L...
Leukemia. 30 (2016) 10 - p. 2080-2083 , 2016

Link: https://doi.org/10.1038/..

12

T-cell ligands modulate the cytolytic activity of the CD33/..:

Laszlo, G S ; Gudgeon, C J ; Harrington, K H.
Blood Cancer Journal. 5 (2015) 8 - p. e340-e340 , 2015

Link: https://doi.org/10.1038/..

13

The treatment-related mortality score is associated with no..:

Buckley, S A ; Othus, M ; Estey, E H.
Blood Cancer Journal. 5 (2015) 1 - p. e276-e276 , 2015

Link: https://doi.org/10.1038/..

14

Effects of short read quality and quantity on a de novo ver..:

Garcia, T.I. ; Shen, Y. ; Catchen, J....
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 155 (2012) 1 - p. 95-101 , 2012

Link: https://doi.org/10.1016/..

15

A Microsatellite Genetic Linkage Map for XiphophorusSequenc..:

Walter, R B ; Rains, J D ; Russell, J E...
Genetics. 168 (2004) 1 - p. 363-372 , 2004

Link: https://doi.org/10.1534/..